These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21357923)

  • 21. [Inflammatory bowel disease: genotype-fenotype relationship].
    Gómez de la Concha E
    An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
    Dideberg V; Kristjansdottir G; Milani L; Libioulle C; Sigurdsson S; Louis E; Wiman AC; Vermeire S; Rutgeerts P; Belaiche J; Franchimont D; Van Gossum A; Bours V; Syvänen AC
    Hum Mol Genet; 2007 Dec; 16(24):3008-16. PubMed ID: 17881657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CARD15 single nucleotide polymorphisms 8, 12 and 13 are not increased in ethnic Danes with sarcoidosis.
    Milman N; Nielsen OH; Hviid TV; Fenger K
    Respiration; 2007; 74(1):76-9. PubMed ID: 16397396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of inflammatory bowel disease: population aspects.
    Hemminki K; Bermejo JL; Försti A
    Gastroenterology; 2008 Jun; 134(7):2190-1. PubMed ID: 18485911
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications.
    Achkar JP; Fiocchi C
    Am J Gastroenterol; 2009 Jul; 104(7):1734-6. PubMed ID: 19436278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
    McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
    Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptotic equivalence between two score tests for haplotype-specific risk in general linear models.
    Xie R; Stram DO
    Genet Epidemiol; 2005 Sep; 29(2):166-70. PubMed ID: 16025443
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases].
    Bouma G; Peña AS
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2414-20. PubMed ID: 10608975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population.
    Browning BL
    Gut; 2006 Jul; 55(7):1050; author reply 1050. PubMed ID: 16766759
    [No Abstract]   [Full Text] [Related]  

  • 31. Functional SFTPD gene variants are not associated with susceptibility to inflammatory bowel disease in the German population.
    Glas J; Seiderer J; Tillack C; Paschos E; Wetzke M; Diegelmann J; Czamara D; Brand S
    Inflamm Bowel Dis; 2011 Jun; 17(6):1439-40. PubMed ID: 21560203
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes.
    Fischer A; Nothnagel M; Franke A; Jacobs G; Saadati HR; Gaede KI; Rosenstiel P; Schürmann M; Müller-Quernheim J; Schreiber S; Hofmann S
    Eur Respir J; 2011 Mar; 37(3):610-6. PubMed ID: 20650992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic aspects of inflammatory bowel disease.
    Hugot JP
    Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():23-37; discussion 37-9. PubMed ID: 11490625
    [No Abstract]   [Full Text] [Related]  

  • 34. MDR1C3435T polymorphism and inflammatory bowel disease.
    Malik MA
    Saudi J Gastroenterol; 2015; 21(2):121-2. PubMed ID: 25843201
    [No Abstract]   [Full Text] [Related]  

  • 35. Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis.
    Calender A; Lim CX; Weichhart T; Buisson A; Besnard V; Rollat-Farnier PA; Bardel C; Roy P; Cottin V; Devouassoux G; Finat A; Pinson S; Lebecque S; Nunes H; Israel-Biet D; Bentaher A; Valeyre D; Pacheco Y;
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31023854
    [No Abstract]   [Full Text] [Related]  

  • 36. Solving the Conundrum: Immunogenetics of Sarcoidosis.
    Kaminski N; Drake WP
    Am J Respir Crit Care Med; 2015 Sep; 192(6):652-4. PubMed ID: 26371809
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic predisposition to cutaneous sarcoidosis.
    Shahkarami S; Rezaei N
    Acta Med Iran; 2012; 50(10):721-2. PubMed ID: 23275292
    [No Abstract]   [Full Text] [Related]  

  • 38. RIP2 polymorphisms in inflammatory bowel diseases.
    Thiébaut R; Douchin V; Jung C; Merlin F; Colombel JF; Lemann M; Almer S; Tysk C; O'Morain C; Gassull M; Finkel Y; Zouali H; Pascoe L; Hugot JP
    Inflamm Bowel Dis; 2011 Apr; 17(4):1055. PubMed ID: 20645315
    [No Abstract]   [Full Text] [Related]  

  • 39. Monothematic meeting of the GISC.
    Annese V
    Dig Liver Dis; 2000 Mar; 32(2):178. PubMed ID: 10975794
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetics of inflammatory bowel disease: a puzzle with contradictions?
    Schreiber S
    Gut; 2000 Dec; 47(6):746-7. PubMed ID: 11076868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.